Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
      
    
    
  
    
      
        Comín-Colet J, Manito N, Segovia-Cubero J, Delgado J, García Pinilla JM, Almenar L, Crespo-Leiro MG, Sionis A, Blasco T, Pascual-Figal D, Gonzalez-Vilchez F, Lambert-Rodríguez JL, Grau M, Bruguera J; LION-HEART Study Investigators.
        
      
    
    Comín-Colet J, et al.
    Eur J Heart Fail. 2018 Jul;20(7):1128-1136. doi: 10.1002/ejhf.1145. Epub 2018 Feb 6.
    Eur J Heart Fail. 2018.
  
  
  PMID: 29405611
  
  
    
  
  Clinical Trial.